Stock NURECA NURECA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nureca Limited Bombay S.E.

Equities

NURECA

INE0DSF01015

Medical Equipment, Supplies & Distribution

Market Closed - Bombay S.E.
Other stock markets
 11:00:57 05/07/2024 BST 		5-day change 1st Jan Change
282.4 INR +1.95% Intraday chart for Nureca Limited +5.14% -33.94%
05-15 Nureca Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
05-15 Nureca Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2021 2022 2023 2024
Capitalization 1 6,011 13,682 2,996 2,553
Enterprise Value (EV) 1 5,192 12,799 2,008 1,439
P/E ratio 9.69 x 30.4 x -36.3 x -142 x
Yield 0.33% 0.22% - -
Capitalization / Revenue 2.82 x 5.35 x 2.69 x 2.78 x
EV / Revenue 2.43 x 5.01 x 1.8 x 1.56 x
EV / EBITDA 8.47 x 23.5 x -12.2 x -12.3 x
EV / FCF -31.6 x 354 x 12.3 x 2,163 x
FCF Yield -3.16% 0.28% 8.15% 0.05%
Price to Book 3.69 x 6.73 x 1.54 x 1.32 x
Nbr of stocks (in thousands) 10,000 10,000 10,000 10,000
Reference price 2 601.0 1,368 299.6 255.3
Announcement Date 07/09/21 16/08/22 28/06/23 25/06/24
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales 1 619 994.3 2,135 2,555 1,113 919.3
EBITDA 1 90.16 93.97 612.6 545.1 -165.1 -117.3
EBIT 1 89.98 93.2 611.4 540.3 -173.9 -125.7
Operating Margin 14.54% 9.37% 28.64% 21.14% -15.62% -13.67%
Earnings before Tax (EBT) 1 88.41 86.08 623.3 609.8 -107.4 -25.44
Net income 1 62.26 63.95 463.7 449.6 -82.5 -17.94
Net margin 10.06% 6.43% 21.73% 17.59% -7.41% -1.95%
EPS 2 8.890 9.136 62.04 44.96 -8.250 -1.794
Free Cash Flow 1 -6.132 -103.5 -164.2 36.18 163.6 0.665
FCF margin -0.99% -10.41% -7.69% 1.42% 14.7% 0.07%
FCF Conversion (EBITDA) - - - 6.64% - -
FCF Conversion (Net income) - - - 8.05% - -
Dividend per Share - - 2.000 3.000 - -
Announcement Date 13/11/20 13/11/20 07/09/21 16/08/22 28/06/23 25/06/24
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt 1 3.19 97.1 - - - -
Net Cash position 1 - - 819 883 987 1,114
Leverage (Debt/EBITDA) 0.0354 x 1.033 x - - - -
Free Cash Flow 1 -6.13 -103 -164 36.2 164 0.67
ROE (net income / shareholders' equity) 129% 55.9% 52.1% 24.5% -4.14% -0.92%
ROA (Net income/ Total Assets) 36.8% 20.3% 34.8% 16.7% -5.11% -3.81%
Assets 1 169 315.1 1,333 2,695 1,615 470.3
Book Value Per Share 2 11.40 21.30 163.0 203.0 195.0 193.0
Cash Flow per Share 2 0.1600 0.1100 17.20 8.250 0.5000 14.10
Capex 1 1.19 4.12 4.25 34 3.96 10.9
Capex / Sales 0.19% 0.41% 0.2% 1.33% 0.36% 1.18%
Announcement Date 13/11/20 13/11/20 07/09/21 16/08/22 28/06/23 25/06/24
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.50% 178B
MEDTRONIC PLC Stock Medtronic plc
-6.68% 98.95B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-7.22% 66.14B
DEXCOM, INC. Stock DexCom, Inc.
-9.87% 44.11B
CENCORA, INC. Stock Cencora, Inc.
+6.78% 43.82B
HOYA CORPORATION Stock Hoya Corporation
+10.10% 42.74B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+11.51% 28.92B
TERUMO CORPORATION Stock Terumo Corporation
+18.89% 25.06B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.68% 23.38B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. NURECA Stock
  4. NURECA Stock
  5. Financials Nureca Limited